HC Wainwright Brokers Lift Earnings Estimates for KPTI
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Free Report) – Equities researchers at HC Wainwright raised their Q1 2026 earnings per share (EPS) estimates for Karyopharm Therapeutics in a report issued on Wednesday, February 18th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings of ($1.17) per share for the quarter, up from [...]